Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sangamo Therapeutics
(NQ:
SGMO
)
0.4541
+0.0241 (+5.60%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 1, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Sangamo Therapeutics
< Previous
1
2
3
Next >
Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
November 15, 2023
Shares of Shapeways Holdings, Inc. (NASDAQ: SHPW) tumbled during Wednesday’s session following downbeat results.
Via
Benzinga
Where Sangamo Therapeutics Stands With Analysts
November 06, 2023
Via
Benzinga
What 8 Analyst Ratings Have To Say About Sangamo Therapeutics
November 06, 2023
Via
Benzinga
Analyst Ratings for Sangamo Therapeutics
August 15, 2023
Via
Benzinga
A Preview Of Sangamo Therapeutics's Earnings
August 07, 2023
Via
Benzinga
The Latest Analyst Ratings for Sangamo Therapeutics
May 01, 2023
Via
Benzinga
Sangamo Therapeutics's Return On Capital Employed Overview
May 01, 2023
Via
Benzinga
What To Know About RBC Capital's Downgrade of Sangamo Therapeutics
November 03, 2023
Via
Benzinga
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
November 02, 2023
Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders.
Via
Benzinga
Sangamo Therapeutics's Earnings Outlook
April 25, 2023
Via
Benzinga
Earnings Scheduled For November 1, 2023
November 01, 2023
Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
October 05, 2023
On Thursday, 369 companies hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
September 26, 2023
On Tuesday, 386 stocks made new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
August 31, 2023
Via
Benzinga
Why NovoCure Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 28, 2023
Gainers Mobile Infrastructure Corporation (NASDAQ: BEEP) shares jumped 98.7% to $12.02.
Via
Benzinga
Untapped Potential: 3 Stocks Tackling the Toughest Rare Diseases
August 25, 2023
Treating rare diseases is a tough but potentially lucrative business. With clinical trials coming due, here are three stocks to buy.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
August 18, 2023
We're starting the final day of trading this week with a dive into the biggest pre-market stock movers worth watching for Friday!
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
May 31, 2023
During Wednesday's session, 212 companies made new 52-week lows.
Via
Benzinga
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In May
May 11, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
May 08, 2023
On Monday, 61 companies hit new 52-week lows.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2023
April 28, 2023
Via
Benzinga
Soon After Novartis & Biogen Walked Away From Neurology Drug Partnerships, Sangamo Announces Major Restructuring
April 27, 2023
Sangamo Therapeutics Inc (NASDAQ: SGMO) announced cutting 27% of its workforce, prioritizing its pipeline, and changing its corporate structure to save about $31 million to fund operations for at least...
Via
Benzinga
This Biotech's Stock Has Been Under Pressure, Could Upcoming Clinical Trials Of Its Nanotechnology-Based COVID Drug Candidate Be The Start Of An Upward March?
April 19, 2023
A company that seems to have seen poor market sentiment lately is NanoViricides Inc. (NYSEAMERICAN: NNVC), a pharmaceutical company specializing in the development of nanomedicine drugs for treating...
Via
Benzinga
7 Sorry Pharma Stocks to Sell in April Before It’s Too Late
April 16, 2023
You have to be patient when investing in pharma stocks. But sometimes the risk and the wait aren't worth the rewards.
Via
InvestorPlace
Boeing, Spirit AeroSystems And Other Big Stocks Moving Lower In Friday's Pre-Market Session
April 14, 2023
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
April 10, 2023
Monday's session saw 114 companies set new 52-week lows.
Via
Benzinga
The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket
March 25, 2023
Moving forward, CRISPR could revolutionize the way we treat thousands of diseases. The best CRISPR stocks will profit from it.
Via
InvestorPlace
Two Big Pharma Companies Bow Out Of Neurology Drug Partnerships With Sangamo
March 20, 2023
Two big-name partners have walked away from partnerships with Sangamo Therapeutics Inc (NASDAQ: SGMO) over a few days.
Via
Benzinga
UBS Group, Credit Suisse And Other Big Stocks Moving Lower In Monday's Pre-Market Session
March 20, 2023
U.S. stock futures traded mostly lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
March 17, 2023
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.